New Delhi, June 26 : Pharma major GSK Pharmaceuticals and government's Regional Centre for Biotechnology (RCB) on Wednesday launched a joint initiative -- Trust in Science Programme -- to develop doctoral programs in the fields of biostatistics and bioinformatics.
"Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs," the company said in a statement.
"GSK Pharmaceutical Ltd. will provide funding and ensure all course content is shaped to address current industry needs and opportunities. Students with a master's degree in biostatistics, maths, and bioinformatics are eligible for the PhD courses."